BB Biotech AG Overview
Latest ROE for BB Biotech AG: 43.74% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow43.74%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, BBAGF shows a ROE of 43.74%. That is above the sector sector average of 11.75%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about 11.75%. BB Biotech AG is at 43.74%, which is higher that average. That is roughly 272.1% above the sector mean. Use the comparison chart on this page to see how BBAGF stacks up against individual peers as well.
Check the historical chart to see whether BBAGF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare BB Biotech AG with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has BB Biotech AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 43.74%) with ownership activity and broader fundamentals.
